Cannabis

The three main species typically recognized within the Cannabis sativa L. family include Cannabis sativa, Cannabis indica and Cannabis ruderalis. The most well-known compounds found within the cannabis plant are THC, cannabidiol (CBD) and cannabinol (CBN).

CBD Oil: Health Benefits and Risks

There is a growing interest in CBD as a potential drug in the treatment of a wide spectrum of neurologic and neuropsychiatric disorders. However, caution must be taken.

Cannabis and Psychosis

Hemp Seed Oil Health Benefits

Does Smoking Cannabis Indoors Affect Children's Health?

Health Effects of Eating Cannabis (Marijuana)

Can Cannabis Use Alter Sperm DNA?

The Potential Advantages of Patient-Directed Cannabis Therapy

Does CBD Oil Work for Arthritis Pain?

Cannabis Use and Acute Myocardial Infarctions in Young People

Using a Portable Raman Spectrometer for Detection of THC

Synthesizing Cannabis from Yeast

Latest Cannabis News and Research

California continues progressive policies, with restraint, in divisive election year

This year, Gov. Gavin Newsom affirmed abortion access, calling California "a proud reproductive freedom state" and criticizing Republicans across the country for trying to take away families' rights.

18 Oct 2024

Safe storage crucial to prevent child drug poisoning

New data shows that the number of children suffering a seizure after swallowing medications or illegal substances has doubled between 2009 and 2023 in the US. The findings were presented today (Wednesday) at the European Emergency Medicine Congress.

16 Oct 2024

DNA changes from high potency cannabis use may signal psychosis risk

Published in Molecular Psychiatry, this is the first study to suggest that the use of high potency cannabis leaves a distinct mark on DNA, providing valuable insights into the biological impact of cannabis use.

15 Oct 2024

New research explores how campus belonging impacts binge drinking and substance use

Students who feel a sense of belonging at their university are more likely to binge drink than those who do not feel the same connection, according to a new study by researchers at Penn State, the University of California, Santa Cruz and University of Oregon.

12 Oct 2024

Decoding Cannabis: Differentiating Hemp and Marijuana

In this interview conducted at Pittcon 2024 in San Diego, Rabi Musah delves into her innovative use of DART-HRMS and chemometric analysis to differentiate between hemp and marijuana varieties of Cannabis sativa, exploring the forensic and legal implications of these findings.

From Pittcon 10 Oct 2024

Prenatal exposure to cannabinoids impacts adult health in rats

Scientists who exposed pregnant rats to a synthetic cannabinoid that activates the same receptors in the brain as marijuana detected effects of the drug on their offspring, such as cardiovascular problems in females and augmented susceptibility to panic attacks in males, and showed that these adverse effects persisted into adulthood.

3 Oct 2024

Dronabinol shows promise in reducing agitation in Alzheimer's patients

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in patients with Alzheimer's by an average of 30%.

2 Oct 2024

Smartphone-based AI systems track subtle facial, pupil signals to identify depression

It has been estimated that nearly 300 million people, or about 4% of the global population, are afflicted by some form of depression. But detecting it can be difficult, particularly when those affected don't (or won't) report negative feelings to friends, family or clinicians.

30 Sep 2024

Lower attention ability in adolescence can predict substance use in young adulthood

Lower attention ability in adolescence can predict cigarette and cannabis use in young adulthood, according to new research from Trinity College Dublin.

30 Sep 2024

Study highlights inequities in emergency care for unintentional ingestions in children

Unintentional injuries like falls, drownings and poisonings are the leading cause of death in patients ages 1-4, and a significant portion of these deaths are linked to unintentional ingestions-;such as swallowing a drug or poison.

27 Sep 2024

Study highlights urgent need for improved care for schizophrenia

New research finds that adults with schizophrenia spectrum disorders have high rates of comorbid mental and substance use disorders and significant social and economic disadvantages, and only 26% received minimally adequate treatment.

23 Sep 2024

Trends in cannabis use among older adults in Michigan

Research indicates a surge in cannabis use among older Michiganders, emphasizing health benefits, driving risks, and the importance of provider communication.

17 Sep 2024

Study reveals significant increase in drug overdoses in Colombia among young women

Overdose rates in Colombia involving illegal opioids, hallucinogens, stimulants and sedative psychotropic medication increased greatly during 2018-2021, mainly caused by overdoses in young women, according to a study at Columbia University Mailman School of Public Health.

12 Sep 2024

Cannabidiol shows promise in treating cognitive disorders

Research reviews the therapeutic potential of cannabidiol (CBD) in treating cognitive impairments, highlighting positive effects in some trials while emphasizing the need for more comprehensive studies.

12 Sep 2024

New insights into the genetics of schizophrenia

In the complex landscape of mental health research, a new peer-reviewed viewpoint offers a critical examination of how genes and environment conspire to influence schizophrenia risk. Published in Genomic Psychiatry (ISSN: 2997-2388, Genomic Press, New York), this thought-provoking analysis by researchers Natassia Robinson and Sarah E. Bergen from Karolinska Institutet in Stockholm, Sweden, brings together cutting-edge findings from genetics and epidemiology.

11 Sep 2024

Pandemic stress drove young adults to turn to cannabis

Study explores how the COVID-19 pandemic influenced increased cannabis use among young adults, highlighting key gender differences in coping mechanisms.

9 Sep 2024

Cannabidiol shown to extend lifespan and improve symptoms in Leigh syndrome models

A study led by the UAB Institut de Neurociències and published in the journal Nature Communications demonstrates in animal models how daily administration of cannabidiol (CBD), a substance obtained from the cannabis plant, extends lifespan and improves symptoms associated with Leigh syndrome.

6 Sep 2024